Cane Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Cane Capital Partners's MRK Position: Q3 2026 in Review
Cane Capital Partners reduced its Merck (MRK) stake by 5.1% in Q3 2026, selling an estimated $22.4K and leaving 3,035 shares worth $441K. The position accounts for 0.16% of the portfolio, ranked #92.
Cane Capital Partners first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Cane Capital Partners held 3,035 shares of Merck worth $441K as of Q3 2026.
- Cane Capital Partners sold 162 Merck shares in Q3 2026, an estimated $22.4K.
- Merck made up 0.16% of Cane Capital Partners's portfolio in Q3 2026, its #92 holding.
- Cane Capital Partners first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
- 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Cane Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.